KOS AI Argus KOS AI, a Silicon Valley health technology firm, has developed a non-invasive glucose monitoring device t ...

A new technology is offering hope to men with low to intermediate-risk prostate cancer by providing a less invasive treatment ...

Debiopharm further describes AbYlink as a one-step method that results in stable conjugation at defined and invariable sites on the Fc domain of an antibody, with no impact on antigen-binding regions, ...

This milestone further strengthens Nexalin’s intellectual property portfolio and affirms the potential of its proprietary Deep Intracranial Frequency Stimulation (DIFS™) technology, a non-invasive and ...

AbYlink is a regio-selective bioconjugation technology ideally suited for preparing conjugates for use in therapeutic and non-invasive diagnostic applications. Oncodesign Services will use this ...

As well as being non-invasive, Crainio’s technology could reduce the cost of determining intracranial pressure and make it possible to make measurements in the field, shortly after injuries occur.